Baragi, Vijaykumar M <br/><br/>
A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.  [electronic resource] 

 -  Arthritis and rheumatism  Jul 2009 
 - 2008-18 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.24629  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cartilage, Articular--drug effects<br/>Cattle<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Interleukin-1alpha--pharmacology<br/>Iodoacetates--pharmacology<br/>Iodoacetic Acid--adverse effects<br/>Male<br/>Matrix Metalloproteinase Inhibitors<br/>Musculoskeletal System--drug effects<br/>Oncostatin M--pharmacology<br/>Osteoarthritis--chemically induced<br/>Rats<br/>Rats, Sprague-Dawley<br/>Treatment Outcome